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Introduction
The practice of routine screening for distress in cancer populations has been gaining worldwide support over the past several years with the conceptualization of distress as the sixth vital sign (Bultz & Carlson, 2006) . The Union for International Cancer Control (UICC) recently endorsed distress as the sixth vital sign, paving the way for universal acknowledgement of the importance of monitoring for distress (UICC, 2010) . Accreditation Canada has also incorporated the expectation of routine screening for distress as a standard of care within the Qmentum Program for Cancer Care and Oncology Services (http://www.accreditation.ca/accreditation-programs/qmentum/).
Across Canada, experience with screening for distress is growing, as cancer facilities plan and implement screening programs. Early learning from these efforts has emphasized the need for a programmatic approach and the importance of oncology nurses in screening and providing the initial response to distress. Patient self-reporting of symptoms that are causing distress is the "gold standard" and an intentional effort to understand and respond to the patients' perspective is the hallmark of patient-centred care (Stewart, 2001) . However, asking patients to complete a screening tool or instrument is not helpful if there is no follow-up action by health care providers based on the screening scores (Coyne, Thompson, Palmer, Kagee, & Maunsell, 2000; Howell, Currie, Mayo, Jones, Boyle, Hack, et al., 2009) .
To date, very little has been written from a nursing perspective about screening for distress and implementing a programmatic approach to screening in a clinical setting. There remains confusion on the part of nurses about how screening for distress using a standardized tool fits into their practice, and how it is different from their usual practice of assessing distress. Considerable learning is required to understand how best to incorporate standardized screening for distress into routine practice, as well as how screening can improve quality of care.
This article has several objectives: (1) describe the current thinking about screening for distress; (2) explore conceptually how screening for distress is an integral part of oncology nursing practice; and (3) share early learning/experiences of cancer nurses in screening for distress initiatives. It is anticipated that this information will help cancer nurses understand how to use a routine screening tool for the benefit of patients and enhancing person-centred care in their own practice. Sharing the early learning gleaned from actual implementation will assist others in overcoming the barriers or challenges that may emerge during the introduction of screening for distress in a clinical setting.
What is distress?
Cancer and its treatment have more than a physical impact, with emotional, psychosocial, spiritual, and practical consequences, as well (Fitch, 2008) . These may occur at any time throughout the person's experience with the disease, as patients confront the reality of their situation and seek ways to cope with what is happening to them and their family. Distress is a common response across the cancer journey for both patients and their families.
Distress is conceptualized as an unpleasant experience of an emotional, psychological, social or spiritual nature that interferes with the ability to cope with cancer (NCCN, 2010) . It "extends along a continuum, ranging from common normal feelings of vulnerability, sadness, and fears to problems that can become disabling, such as, depression, anxiety, panic, social isolation, and existential and spiritual crisis" (NCCN, p. 5). Identifying and responding to this distress is considered a critical aspect of quality cancer care (Carlson & Bultz, 2003; Jacobsen, 2009; Jacobsen, Shibata, Siegel, Lee, Alemany, Brown, et al., 2009) .
Distress is a dynamic phenomenon, rising and falling over time, as events unfold. In particular, it can be elevated for cancer patients at points of transition; these include such times as the initial diagnosis, start of treatment, end of treatment, at the point of recurrence, and during the last days of living (Howell et al., 2009) . The proportion of patients who experience significant levels of distress has been reported Special feature Screening for distress: Responding is a critical function for oncology nurses to range from 35% to 45% (Zabora, BrintzenhofeSzoc, Curbow, Hooker, & Piantadosi, 2001) . Screening programs in regional cancer centres in Canada (Carlson, Angen, Cullum, et al., 2004 ) have documented similar rates of significant levels of distress. These levels vary by disease site, as well as by stage of disease, but are not entirely related to disease factors alone. While there are common elements to the cancer journey, no two individuals respond in exactly the same manner. Social supports, past history, coping style and a variety of other personal variables all contribute to the variation in distress (Weisman, 1976; Folkman & Greer, 2000) . Families of cancer patients are also affected by the disease of their loved ones, often experiencing emotional distress, changes in roles and relationships, financial pressure, caregiver burden, fear of losing their loved one and grief (Grunfeld, Coyle, Whelan, Clinch, Reyno, Earle, et al., 2004; Longo, Fitch, Deber, & Williams, 2006) .
There are good reasons for nurses to be alert for the signs of distress. Elevated distress is associated with poor quality of life across multiple domains (Sanson-Fisher, Girgis, Boyes, Bonevski, Burton, Cook, et al., 2000; Skarstein, Aass, Fossa, Skovlund, & Dahl, 2000; Wen & Gustafson, 2004) . It is also linked to poor adherence to treatment regimes (Kennard, Smith, Olvera, et al., 2004) , lower satisfaction with care (Von Essen, Larsson, Oberg, & Sjoden, 2002) , and unmet patient needs (Fisch, 2004; Newell, Sanson-Fisher & Savolainen, 2002) . It also accounts for additional visits to physician offices, hospital and emergency rooms, leading, ultimately, to increased costs for cancer care (Carlson & Bultz, 2004; . Additionally, evidence is beginning to accumulate that distress and poor quality of life may also be associated with poor survival outcomes (Brown, Levy, Rosberger, & Edgar, 2003; Groenvold, Petersen, Idler, Bjorner, Fayers, & Mouridsen, 2007) .
Responding to distress: How are we doing?
Across Canada, in various studies, cancer patients have indicated that they experience a number of unmet needs and low satisfaction with cancer care, especially in the areas of emotional support. While respondents rated their overall experience of care highly (95% to 98%); emotional support has been a weak spot that continues to receive substantially lower satisfaction scores than other dimensions with ranges of 48% to 56% (Canadian Partnership Against Cancer, 2010) . Multiple reports have been written describing patient views about what gaps exist in the cancer system and how improvements could be made (IOM, 2008 , Vachon, 2006 Vachon, 1998) . Patients and their families have described the characteristics they believe are important in the type of care they wish to experience. These characteristics include respect for patient preferences, physical comfort, information, education and communication, coordination and continuity of care and ease of access to services (Gerteis, Edgman-Levitan, Daley, & Delbanco, 1993) .
Despite the evidence that cancer patients experience unmet needs and distress, identification and reporting of that distress is often not done routinely in daily clinical practice (IOM, 2008; Vachon, 2006; Plummer, Gourney, Goldberg, et al., 2000; Merckaert, Libert, Delvaux, et al., 2005) . A number of factors influence nurses in terms of their identification, assessment of and response to distress. Many doctors and nurses believe they do assess for distress quite well and a more standardized approach is not needed. However, studies show that oncologists and nurses are not always accurate in identifying patients with significant distress (Fallowfield, Ratcliffe, Jenkins, & Saul, 2001; Mitchell & Kakkadasam, 2010; Mitchell, Hussain, Grainger, & Symonds, 2010) . Nurses report concerns about time constraints preventing more consistent holistic assessments or they feel unprepared to handle the patient's emotional responses that emerge (McLeod, Tapp, Moules, & Campbell, 2010; Botti, Endacott, Watts, Cairns, Lewis, & Kenny, 2006) . It is likely that these two factors are linked (McLeod, et al., 2010) . Others are concerned about the availability of services where patients could be referred to address the psychosocial issues and concerns that are identified. In one study, while nurses did not assess psychosocial distress in any standardized way, when patients or family members asked for help in this area, the help they received generally was reported as very helpful and met the need (McLeod & Morck, 2011) .
While patients may receive help when they ask, there are a number of reasons that likely contribute to the failure to volunteer the fact that they are distressed, or to accept help when it is offered. The words "emotional" or "psychological" or "psychiatric" are stigmatized and individuals do not want to be labelled as such (Barney et al., 2009; Holland, Kelly, & Weinberger, 2010) . Patients and family members have concerns about being perceived as weak and unable to manage. Additionally, patients believe that doctors and nurses are too busy with other patients' treatment concerns and are not interested in the emotional or practical issues (McLeod et al., 2010; . Patients also may be concerned that their treatment could be stopped if they report distress related to uncontrolled side effects or that they may distract their health team from focusing on their treatment. Others have identified that patients vary in their ability to volunteer information and providers vary in their ability to elicit information (IOM, 2008; Richardson, Medina, Brown, & Sitzia, 2007) . It seems very clear that psychosocial and supportive care needs will be unmet unless systematic assessment processes to identify the individual's specific problems and needs are a consistent part of routine clinical practice (Holland, Kelly, & Weinberger, 2010; . Even when distress is identified, however, there are reasons why help may not be accepted.
In several studies, as many as half of the patients who indicated they were experiencing distress because of unmet needs also indicated they did not want assistance at the time of the assessment Fitch, in press; . In a recent qualitative study, patient's perspectives regarding the desire for assistance were explored . The reasons patients indicated they did not want help for unmet needs at a specific point in time were quite varied, including: thinking the concern was expected with cancer treatment and nothing could be done about it (e.g., fatigue); not knowing a service existed and was available to them (e.g., sexuality clinic); believing the cancer care team would be too busy or not interested in helping them with an issue (e.g., how to tell children about diagnosis); and feeling they already had enough to cope with and could not deal with anything more right now.
Recent reports from governmental bodies and leading advocacy agencies have begun to call for improved person-centred or whole person care (Institute of Medicine, 2008; Gerteis et al., 1993) . National and regional cancer control strategic plans contain reference to the inclusion of person-centred care as a hallmark of comprehensive quality cancer care, pointing to the need for whole person assessment and care. Many of the strategic plans incorporate goals about improving the patient experience and decreasing the burden of suffering and emphasize the need to make use of the existing body of evidence to intervene appropriately. There is a robust and growing body of research evidence concerning communication; provision of information and support; management of emotional, psychosocial, and spiritual needs; as well as pain and other symptoms (Hack, Degner, & Parker, 2005; Lepore & Coyne, 2006; Patrick, Ferketich, Frame, Harris, Hendricks, Levin, et al., 2003) . However, it is of critical importance to have concrete strategies and structured, clearly defined approaches and a programmatic structure established in order to achieve the desired outcomes.
A national response: Screening for distress
For busy clinical settings, one concrete strategy recommended to move toward person-centered care is to screen for distress using a standardized tool (Holland, Kelly & Weinberger, 2010; NCCN, 2010; Howell et al., 2009) . Screening is a specific strategy to help identify those individuals with elevated distress who are in need of additional assessment and intervention. Screening is defined as a rapid method of prospectively identifying individuals who are experiencing difficulty. It is a method of triage or rapid identification, as well doi:10.5737/1181912x2211220 as a mechanism for the patient to indicate what is of concern or a problem to him or her at a specific point in time. This indication of concern is a starting point for a person-centred therapeutic relationship between the care provider and the patient. Effective communication and establishment of a therapeutic relationship (Hack, Degner, & Parker, 2005 ) is fundamental to a deeper assessment and an appropriate response or referral to other relevant services (Howell et al., 2009) . Using a standardized tool for screening offers a consistency in data capture and is valuable for comparison over time. It also cues patients with regard to areas that the health care team is concerned about and will monitor over time.
To be successful, screening cannot stand alone. The practice of screening must be embedded in a programmatic approachscreening followed by appropriate assessment using a valid tool to understand the parameters of a specific problem identified with appropriate follow-up action to screening results. Establishing a screening program requires consideration of several program elements: selection of a reliable/valid screening tool; distribution of the tool to the patients; retrieval of the completed tools; scoring of the tool and categorization of the scores; and implementing localized pathways for action based on the scores, including referral of patients with elevated scores and follow-up with the referred patients. Screening must be embedded in a therapeutic relationship (Hack, Degner, & Parker, 2005) with health professionals who can initiate interventions to address the distress or refer to specialized professionals and programs.
At present, in Canada, considerable effort has been undertaken to develop guides for screening for distress and tools to assist clinicians as they implement programmatic approaches (Screening Toolkit, Canadian Partnership Against Cancer [CPAC]). A minimum data set has been identified with the Edmonton Symptom Assessment System (ESAS) (Bruera, Kuehn, Miller, Selmser, & Macmillan, 1991) and the Canadian Problem Checklist recommended for use to capture data regarding a broad range of physical, psychosocial and practical problems or concerns common in cancer (CPAC, 2009) . A conceptual framework for guiding the assessment process and response to scores on the ESAS has been identified (Howell et al., 2009 ) (See Figure 1) . Recommendations have been made that scores of 1 to 3 on the ESAS items suggests low distress, scores of 4-6 suggests moderate distress, and 7 and above are severe distress (Bruera et al., 1991; Cleeland et al., 1994) . The low scores need to be acknowledged by the clinician, but may not require additional intervention beyond standard care assuming that it is of high quality and inclusive of good symptom management, easy access to relevant information, basic emotional support, and effective communication between patient and providers (Fitch, 2008) . Moderate level scores need more assessment to determine what factors are related to onset and severity, what the impact is on the person, what strategies have been effective in managing the symptom so far, and the person's wishes or goals with regard to addressing the symptom. Then, interventions are offered to prevent further escalation and to alleviate the symptom. The highest scores require immediate comprehensive and focused assessment and intervention to alleviate the symptom, treat the problem, and reduce the burden on the patient and family (i.e., at the time of the clinic visit, or by phone, or tele-health/videoconference) (See Figure 2 for scoring algorithm).
Role of oncology nurses in screening for distress
The Canadian Association of Nurses in Oncology has clearly articulated the role of the specialized oncology nurse and outlined both standards of care (what the patient can expect to receive) and practice competencies (what the nurse is expected to provide in caring for cancer patients and their families) (www.cano.ca). Key responsibilities of the specialized oncology nurse include managing symptoms, teaching and coaching, and assisting patients and families to cope with the consequences of the disease and treatment. These responsibilities cannot be completed without astute assessment using valid tools. In turn, that assessment needs to start with, and be based on what is important and of concern to the individual patient. Given that distress is a nurse-sensitive outcome (Howell, 2010) , oncology nurses have a key role in responding to distress screening scores and the multidimensional factors that contribute to distress.
Screening for distress using a standardized tool, such as ESAS and the Canadian Problem Checklist, provides nurses with an initial understanding of the levels of physical and psychological symptom severity and the main problems or issues faced by the patient. The nurse's review of the scores on the screening measure can serve as a mechanism for triage and can facilitate setting priorities for intervention. Routine screening helps to focus the conversation between the patient and the nurse on the sources of distress experienced by the patient. By starting the conversation with the intention of determining the source of the rating of the distress, the nurse can assess needs in a more focused way and intervene appropriately regarding the distress. Interventions by oncology nurses include establishing therapeutic relationships, providing education and supportive counselling, and making appropriate referrals to professional and community services (Corner, 1996; Arnold, 1999) .
Responding to distress has figured prominently in nursing practice and nursing intervention taxonomies (McCloskey & Bulechek, 1996) and distress is considered amenable to nursing interventions (Given & Sherwood, 2005; Fulcher, Badger, Gunter, & Marrs, 2008 This zone is considered a mild level: The patient is managing the problem and has low symptom or emotional distress.
Green Zone Score 1-3
This zone is considered a moderate level: The patient is struggling to manage the problem. Needs to be targeted intervention to get the patient back into the green.
Yellow Zone Score of 4-6
This zone is considered a severe level: Patient problem is out of control and placing them at serious risk and demanding urgent response by the clinic team or referral.
Red Zone Score of 7-10 doi:10.5737/1181912x2211220
Responding to distress is considered an important part of nursing practice, as part of a therapeutic person-centred care approach (MacCormack & McCance, 2006) and interpersonal communication with patients facing illness stressors (Arnold, 1997) . Nurses are the cornerstone to effective relief of pain and other symptoms (McCaffery & Pasero, 1999) . Patient education or psycho-educational interventions along with relaxation and non-pharmacological interventions delivered by nurses are shown to be effective (Howell, 2010) . Outcome-based assessment is recommended, as part of best practice in nursing (Kleinpell, 2001) , and the use of standardized self-report instruments in screening programs provides data to monitor changes in patient response to cancer and treatment over time and allows nurses to gauge the effectiveness of interventions. However, nurses express concern about not feeling valued as contributors in the provision of psychosocial care to reduce distress (Botti et al., 2006) and have expressed a number of additional concerns, as distress screening has evolved across Canada.
Nurses have indicated anecdotally that they are reluctant to screen patients when they don't have resources to assist them to make decisions regarding further assessment and interventions. Careful attention is required to provide localized care pathways for follow-up action and clear expectations about the use of evidence in clinical decision-making regarding intervention selection. Currently, provincial cancer agencies and the Cancer Journey Action Portfolio of the Canadian Partnership Against Cancer are leading the way with the production of clinical practice guidelines and brief algorithms to guide practice related to physical and psychological symptom scores on the ESAS. Recently completed guides include, for example, those on depression and anxiety, fatigue, sleep disturbances (Howell, 2010) , pain, dyspnea, and nausea and vomiting for palliative populations (Cancer Care Ontario, 2011) (See Figure 3 , pages 16-17 for example). More guides are in the planning stages and both provincially and nationally efforts are being made to incorporate these guides in practice. For example, Cancer Care Ontario has developed applications on hand-held devices (iPhone apps; Windows Phone 7) to allow easy access to the algorithms wherever the nurse and patient are located, thus overcoming the reliance on paper or access to computers.
Ultimately, localized care pathways need to be organized for the specific actions in a local setting. Introducing a programmatic screening approach requires a clear designation about who will respond to the scores initially, and how assessment and intervention will occur by members of specific disciplines within specified scopes of practice. It is important that one does not screen without follow-up and action based on the screening results or scores. This requires an inter-professional team approach in the clinical setting together with effective partnerships with community-based organizations. Frequently, the full range of services cannot be available in one facility. However, the full complement of services may be available across a region and made available to patients and families through partnership arrangements (Fitch, 2008) . Figure 4 (page 18) outlines the generic process a nurse would follow in responding to screening scores from a standard tool in a clinical situation. When the patient completes the screening instrument (either on paper or on a computer touch screen) the nurse uses the results to open the dialogue and further assess the intensity of the concern, its impact and meaning for the patient. This opening conversation provides a brief review of the patient responses on the screening tool and the patient's reasons for answering with specific scores. Based on what is shared during this interaction, the nurse must decide about the need for further exploration of the concerns and a more focused assessment. As the nurse learns more from the patient about his or her situation, the nurse determines the necessary course of action or intervention. The nurse intervenes with non-pharmacological approaches within the scope of the specialized oncology nursing role or may consult with other members of the health care team and intervene through a collaborative approach (for example, advocating for pharmacological interventions, such as pain analgesics). The nurse may also refer the patient to another member of the inter-professional team for specific assessment and intervention.
What are the challenges and barriers in introducing a standardized screening tool?
To date, relatively little has been written about implementing a screening for distress program from a nursing perspective, or about the challenges that could be experienced. Vodermaier and Linden (2008) reported that 36.5% of the 146 respondents to their national survey of Canadian cancer programs were using a standard tool for distress screening in their practice settings. The challenges reported concerning the difficulties in implementing the use of a standardized tool included time pressures for staff to complete and score the screening tool (n = 11), difficulties in applying the screening in a consistent manner (n = 9), attitudinal buy-in by health care staff (n = 9), and problems with follow-through once a positive screening result was obtained (n = 4). This work did not focus specifically on nursing perspectives.
In preparation for this manuscript, oncology nursing leaders who have been engaged in implementing screening for distress programs were consulted regarding the key challenges and benefits for oncology nurses that they had observed as they engaged in implementing a screening for distress program. The perspectives these nurse leaders described regarding implementation of screening for distress are summarized in Table 1 (page 18).
The major challenges for oncology nurses revolved around the understanding and beliefs about screening and the current interpretation of the oncology nursing role. A primary challenge was the perception of screening as an "add on" to daily work rather than seeing it as an aid to triage and an integral part of nursing practice. A second major challenge revolved around the interpretation of the oncology nursing role in many cancer programs. The nurse leaders shared the perspective that the role of the oncology nurse has been eroded over the last decade because of a number of workload and organizational factors. The result is a wide variation in practice concerning oncology nurses' engagement in psychosocial assessment and intervention. Screening for distress implementation provides an opportunity to reaffirm this important aspect of practice. However, success will require nursing staff to embrace distress as a nurse sensitive outcome and gain comfort and confidence in providing effective psychosocial care and evidence-based symptom management.
The benefits oncology nurse leaders have observed during their exposure to screening for distress implementations are also listed in Table 1 . A key benefit has been the reaffirmation and acknowledgement of the role of nurses as specialized oncology nurses with key contributions to make in managing symptoms and psychosocial distress. The nursing staff members have been able to focus their practices and enhance their capacity to engage in assessment and intervention regarding both psychosocial care and symptom management. Nursing leaders see that the psychosocial care of patients has been improved and is focused on what patients are saying is important to them. The conversations between nurses and patients are including topic areas that were not part of the conversations nurses and patients had been having in the past. Patients' perceptions about what is important to them serve as the starting point for the dialogue with patients.
These nurse leaders also identified critical success factors in implementing screening for distress as a programmatic approach (See Table 1 ). An essential factor in achieving the desired outcome is the access nurses have to appropriate practice-based education and clinical support during the implementation of screening for distress. Providing education has been a key strategy to help nurses know how to perform effective psychosocial assessments and symptom management interventions in busy clinical environments. �nterventions for all patients, as appropriate� ESAS score 1 to 3� ESAS score 4 to 6 � ESAS score 7 to 10�
NON-PHARMACOLOGICAL
� Psycho-social-spiritual interventions (patient education, counseling, recreational activities, relaxation therapy imagery, social interaction, spiritual counselling). � Other therapies (physiotherapy, occupational therapy, massage, aromatherapy, music therapy, acupuncture, transcutaneous electrical nerve stimulation, reflexology, Reiki, hypnotherapy). � Other interventions such as radiation therapy, vertebroplasty, surgery and anesthetic interventions should be considered in patients with difficult to control pain.
Patient Education
� Taking routine and breakthrough analgesics, adverse effect management, non pharmacologic measures that can be used in conjunction with pharmacologic treatment.
PHARMACOLOGICAL
� The severity of pain determines the strength of analgesic required specified by the World Health Organization (WHO) Analgesic Ladder. � The type and cause of the pain will influence the choice of adjuvant analgesic (e.g. nociceptive, neuropathic, bone metastases). � In the presence of reduced kidney function all opioids should be used with caution and at reduced doses and/or frequency. � Fentanyl, methadone and oxycodone are the safest opioids of choice in patients with chronic kidney disease. � Methadone requires an experienced prescriber, check for significant drug interactions before prescribing any drug to a patient on methadone. � When using a transmucosal fentanyl formulation for breakthrough pain the effective dose should be found by upward titration independent of the regular opioid dose. � For those with stabilized severe pain and on a stable opioid dose or those with swallowing difficulties or intractable nausea and vomiting, fentanyl transdermal patches may be appropriate, provided the pain is stable.
� Classify the pain � nociceptive, neuropathic or mixed? � The type and cause of the pain will influence the choice of adjuvant analgesic (e.g. nociceptive, neuropathic, bone metastases). � The choice of antidepressant or anticonvulsant should be based on concomitant disease, drug therapy and drug side effects and interactions experienced. � There is insufficient evidence to support a recommendation for topical opioids. � There is insufficient evidence to support first or second line therapy of cancer pain with cannabinoids but they may have a role in refractory pain, particularly refractory neuropathic pain. � Transdermal fentanyl should not be used in opioid naïve patients. � Specialist palliative care advice should be considered for the appropriate choice, dosage and route of opioid in patients with reduced kidney function or in patients with difficult to control pain.
ADVERSE EFFECTS OF OPIOIDS
� Many opioid-naïve patients will develop nausea or vomiting when starting opioids, tolerance usually occurs within 5-10 days. Patients commencing an opioid for moderate to severe pain should have access to an antiemetic to be taken if required.
� The majority of patients taking opioids for moderate to severe pain will develop constipation. Little or no tolerance develops. The commonest prophylactic treatment for preventing opioid-induced constipation is a combination of stimulant (senna or bisocodyl) and osmotic laxatives (lactulose or PEG 3350).
Screen for pain using ESAS at each visit� � Morphine starting dose is usually 5mg
Q4h with 2.5-5mg Q1H prn for breakthrough pain. For elderly or debilitated patients consider a starting dose of 2.5mg Q4h. � Hydromorphone starting dose is 1mg
Q4h with 0.5-1mg Q1h prn for breakthrough pain. For elderly or debilitated patients consider a starting dose of 0.5 mg Q4h. � Oxycodone starting dose is 2.5 mg or one half tablet Q4H with 2.5 mg or one half tablet Q2H prn for breakthrough.(The lowest dose oxycodone tablets available, either in combination with acetaminophen or alone, contain 5mg of oxycodone, equivalent to ~5-10mg of morphine).
� If the person is taking an opioid:
� As an immediate release preparation with q4h dosing, increase the regular and breakthrough doses by 25%. � As a sustained release opioid, increase this dose by 25%. Change the breakthrough dose to 10% of the regular 24h dose, either q1-2h PRN PO or q30 min PRN subcut. � Patients with stable pain and analgesic usage, receiving oral morphine, oxycodone or hydromorphone should have the drug converted to a sustained or controlled release formulation given q12h for ease of administration. The short acting breakthrough dose is usually 10% of the total daily dose. � The frequency of breakthrough doses for oral opioids is Q1-2h prn. After conversion to a long acting preparation, if pain is not well controlled, reassess the patient and consider why multiple breakthrough doses are being used and the effectiveness of the breakthrough doses. � If indicated after proper assessment, the daily dose can be titrated by adding 20 to 30% of the breakthrough doses used in the preceding 24 hrs to the daily sustained release formulation. � Make frequent assessments and adjustments to the opioid dose until the pain is better controlled.� � 2. Consider a consultation to palliative care or a cancer pain specialist.
3. If IV access is present, and the person is opioid naïve give stat morphine 5-10 mg IV q10min until pain is relieved; if the person is on opioids give the po prn dose IV q10min until pain is relieved. Monitor carefully.
4. If no IV access available, and the person is opioid naïve give stat morphine 5-10 mg subcut q20-30min until pain is relieved; if the person is on opioids give the po prn dose subcut q20-30min until pain is relieved.
5. Titrate dose by 25% every 1 -2 doses until pain is relieved.
6. When pain is controlled: If the patient is taking a sustained release opioid increase this dose by 25% and change to q4h dosing po or subcut. Do Not try to manage a severe pain crisis with a long-acting opioid. Change the breakthrough dose to half of the regular dose, either q1h PRN PO or q30 min PRN subcut. Meeting the education needs of nurses As articulated above, nurses need to understand the screening process, how to interpret scores and the guidelines to address identified problems. Nurses also need to feel confident about their ability to implement these tools and guidelines smoothly and efficiently within the context of their daily practice. In the national screening for distress project, local implementation teams address some of these needs. In addition, however, a national education program providing more in-depth education was created to support nurses, as they implemented screening programs.
The Inter-professional Psychosocial Oncology Distance Education (IPODE) project, an initiative of the Canadian Association of Psychosocial Oncology (CAPO), developed a program with funding from the Canadian Partnership Against Cancer. This six-hour independent study program is freely available on-line (www.ipode. ca/screening) and addresses such things as the need for screening, how to discuss screening results with patients and family members, and how to handle referrals. It also provides a review of therapeutic relationships, communication and supportive counselling. The program was launched in 2010 and, to date, has had more than Critical success factors for uptake of screening for distress
Benefits of screening for distress with active engagement of oncology nurses
• workload will be increased by adding on screening • flow of clinic appointments will be delayed as clinicians manage screening issues • there is not enough time to do screening and patients will not fill in long forms • screening is not part of their (nurses') role or responsibility • screening is just one more thing that has been added onto the day's work and is just one more questionnaire to be filled in • patients do not want help with some of the issues, so why bother screening • screening and talking about the issues will add to the patients' distress • they are already doing screening about the issues anyway and the tool will not add anything additional • how to deal with the distress and concerns that are identified; how to deal with all the issues that will emerge • there will be no place or service where referrals can be made once patient problems are identified • existing services will be overwhelmed by the number of referrals that will be needed once screening happens • confusion between screening and assessment • which tool(s) to use-are they appropriate for all populations, all settings, all stages of cancer experience?
• that nurses are responsive to their symptoms and that the nurses provide comfort, both physical and emotional on a consistent basis being able to focus the conversation streamlines interaction and can save time; "you are going down the right road sooner"; the tool is most useful in focusing conversations • the teamwork is more cohesive and collaborative; professions are more aware of one another's scope of practice; communication among the team members is improved; the team members are all talking the same language • having screening for distress introduced is driving practice change and is shaping practice; there is more consistency and continuity of nursing care; the workflow and workload is shifting; nurses are taking more leadership around psychosocial care and symptom management • the referrals to other disciplines address key issues within their scope of practice • documentation is more apt to occur • tracking and monitoring individual patient concerns is easier to assess the impact of screening and interventions • having an organized database with our own patients' information is very powerful; we can review trends in patient concerns and use the data for program planning and resource allocation arguments; you can see where the gaps are in services • the needs for education are more easily identified; there is ability to mobilize resources for the necessary education; having the screening tool in use helps with identification of learning needs and helps with setting performance appraisal goals doi:10.5737/1181912x2211220 400 participants, including international participants. Evaluation suggests the program is highly effective in increasing nurses' confidence with screening, providing supportive counselling and making complex referrals. In particular, videotaped examples of nurses discussing screening results and providing initial intervention were identified as very effective in helping nurses to address patient needs (McLeod & Morck, 2011) . Although these education initiatives are helpful, ongoing support and mentoring would strengthen the learning obtained through formal programs such as this.
Conclusion
Oncology nurses have a critical function to provide high-quality, comprehensive patient care by screening for distress (sixth vital sign). As direct care providers of psychosocial care and symptom management, oncology nurses can use a standardized screening tool on a routine basis to initiate dialogue with a patient, focus their assessment and establish an intervention approach that is personcentred and relevant to identified concerns and sources of distress. Using the tool will clearly identify those individuals who would benefit from additional assessment and intervention and help to prioritize care and actions taken. Nurses are critical in early identification of distress and facilitating access to quality care and needed resources. Early lessons from oncology nurse leaders emphasize the need for leaders to articulate and fundamentally support the role and responsibilities of nursing staff in screening, as a triage manoeuvre/step and demystify screening for distress with direct care staff members.
Ultimately, implementing screening for distress and responding effectively will require an inter-professional team effort with a strong emphasis placed on the responsibility of the direct care oncology team working in partnership with other specialists. It is important to ensure the processes for implementation are clear and well conceived and that staff is highly involved in planning the implementation together with nurse leaders. When screening for distress is conceptualized and supported as an integral part of oncology nursing care, there will be change in practice and workflow. Such change can increase the quality of care for cancer patients if addressed strategically and supported by adequate education, resources such as symptom management guides, and mentoring. Education, guides, and mentoring can lead to enhanced job satisfaction for nurses who are empowered to practice to the full scope of their capabilities.
